Summarized by Masters of Longevity from Fight Aging!.
A newsletter surveys inflammation-targeted atherosclerosis therapies, off‑label gene therapy practices, and grip strength as a predictive aging biomarker.
Key Takeaways
- Although age-adjusted cardiovascular mortality has declined in many developed nations, the global burden of atherosclerotic disease continues to rise due to population aging and growth.
- This narrative review examines the evolving understanding of atherosclerosis, which has shifted from a predominantly lipid-centric model to a chronic inflammatory disease.
